GP 122 (Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg)
Pill imprint GP 122 has been identified as Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg.
Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; heart attack; migraine prevention (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 12.5 mg / 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GP 122 (Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg)
- Imprint:
-
GP 122
- Strength:
- 12.5 mg / 20 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-1176
More resources
Hydrochlorothiazide and lisinopril is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
